Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib / Breccia, M; Salaroli, A; Serrao, A; Zacheo, I; Saracino, R; Alimena, Giuliana. - In: LEUKEMIA & LYMPHOMA. - ISSN 1042-8194. - STAMPA. - 55:1(2014), pp. 204-206. [10.3109/10428194.2013.795650]
Application of comorbidity indexes at baseline could be useful to predict rates of response in patients with chronic myeloid leukemia treated with imatinib.
Breccia M;Serrao A;ALIMENA, Giuliana
2014
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.